Evidence map›Paper›PMID 23842002›Full record

ArticleMolecular & cellular proteomics : MCP2013

Proteomic identification of novel secreted antibacterial toxins of the Serratia marcescens type VI secretion system.

Maximilian J Fritsch, Katharina Trunk, Juliana Alcoforado Diniz, Manman Guo, Matthias Trost, Sarah J Coulthurst

Open access · hybridAbstract read
In one paragraph

Article in Molecular & cellular proteomics : MCP, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 61 papers.

0numbers the graph read from it
0cells of the map it votes in
61citing papers in PubMed
10.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

61 citing papers in PubMed, 99 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Prevalence and activity of class II microcins inApplied and environmental microbiology · 2026
    Article
  6. Complete genome sequence ofMicrobiology resource announcements · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Identification of Effectors: Precipitation of Supernatant Material.Methods in molecular biology (Clifton, N.J.) · 2024
    Article
  11. Article
  12. Article
  13. Review
  14. PandemicLife science alliance · 2023
    Article
  15. Article
  16. Transcriptional organization and regulation of theMicrobiology (Reading, England) · 2023
    Article
  17. Article
  18. Article
  19. Article
  20. Article

1 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Maximilian J FritschDivision of Molecular Microbiology and.
Katharina Trunk
Juliana Alcoforado Diniz
Manman Guo
Matthias Trost
Sarah J Coulthurst
MRC Protein Phosphorylation and Ubiquitylation Unit · GB

Funding

Medical Research Council G1100713Medical Research Council MC_UP_A500_1020Medical Research Council MC_UU_12016/5Medical Research Council MR/K000111X/1Medical Research Council MR/K00011X/1
6 · The paper itself

Abstract

It has recently become apparent that the Type VI secretion system (T6SS) is a complex macromolecular machine used by many bacterial species to inject effector proteins into eukaryotic or bacterial cells, with significant implications for virulence and interbacterial competition. "Antibacterial" T6SSs, such as the one elaborated by the opportunistic human pathogen, Serratia marcescens, confer on the secreting bacterium the ability to rapidly and efficiently kill rival bacteria. Identification of secreted substrates of the T6SS is critical to understanding its role and ability to kill other cells, but only a limited number of effectors have been reported so far. Here we report the successful use of label-free quantitative mass spectrometry to identify at least eleven substrates of the S. marcescens T6SS, including four novel effector proteins which are distinct from other T6SS-secreted proteins reported to date. These new effectors were confirmed as antibacterial toxins and self-protecting immunity proteins able to neutralize their cognate toxins were identified. The global secretomic study also unexpectedly revealed that protein phosphorylation-based post-translational regulation of the S. marcescens T6SS differs from that of the paradigm, H1-T6SS of Pseudomonas aeruginosa. Combined phosphoproteomic and genetic analyses demonstrated that conserved PpkA-dependent threonine phosphorylation of the T6SS structural component Fha is required for T6SS activation in S. marcescens and that the phosphatase PppA can reverse this modification. However, the signal and mechanism of PpkA activation is distinct from that observed previously and does not appear to require cell-cell contact. Hence this study has not only demonstrated that new and species-specific portfolios of antibacterial effectors are secreted by the T6SS, but also shown for the first time that PpkA-dependent post-translational regulation of the T6SS is tailored to fit the needs of different bacterial species.

Indexed as

Bacterial ProteinsBacterial Secretion SystemsBacterial ToxinsMass SpectrometryPhosphopeptidesProteomicsSerratia marcescensBacterial ProteinsBacterial Secretion SystemsBacterial ToxinsPhosphopeptides

Identifiers

PMID23842002
PMCPMC3790287
OpenAlexW2103848934

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.